Imlunestrant improved PFS in ESR1-mutated breast cancer compared to standard endocrine therapy, but not significantly in the overall population. Combining imlunestrant with Verzenio enhanced PFS in ...
Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.
image: Mafalda Oliveira, Senior Consultant at the Vall d’Hebron University Hospital’s Medical Oncology Department and Clinical Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback